EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The endocannabinoid system in appetite regulation and treatment of obesity

Marija Kurtov, Igor Rubinić, Robert Likić iD

Pharmacology Research & Perspectives · 2024-10 · 12 (5)

DOI: 10.1002/prp2.70009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 18.09.2024. Verfasst von Marija Kurtov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Toxicology, University Hospital Sveti Duh, Zagreb, Croatia. Hauptthemen laut MEDLINE: Endocannabinoids, Obesity, Appetite Regulation. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endocannabinoid system (ECS) is a complex cell‐signaling system that is responsible for maintaining homeostasis by modulating various regulatory reactions in response to internal and environmental changes. The influence of ECS on appetite regulation has been a subject of much recent research, however, the full extent of its impact remains unknown. Current evidence links human obesity to ECS activation, increased endocannabinoid levels in both central and peripheral tissues, along with cannabinoid receptor type 1 (CBR1) up‐regulation. These findings imply the potential pharmacological use of the ECS in the treatment of obesity. Here, we present various pathophysiological processes in obesity involving the ECS, highlighting different pharmacological options for modulating endocannabinoid activity to treat obesity. However, the potential of those pharmacological possibilities remains under investigation and requires further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsObesityAppetite RegulationHumansAnimalsReceptor, Cannabinoid, CB1Anti-Obesity AgentsSignal Transduction

Substanzen

EndocannabinoidsReceptor, Cannabinoid, CB1Anti-Obesity Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Toxicology, University Hospital Sveti Duh, Zagreb, Croatia.
  • Department of Clinical Pharmacology and Toxicology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
  • University of Rijeka, School of Medicine, Rijeka, Croatia.
  • Department of Clinical Pharmacology and Toxicology, Clinical Hospital Centre Zagreb, Zagreb, Croatia.
  • University of Zagreb, School of Medicine, Zagreb, Croatia.

ORCID-Profile: Robert Likić

Zitieren

APA

Kurtov, M., Rubinić, I., & Likić, R. (2024). The endocannabinoid system in appetite regulation and treatment of obesity. Pharmacology Research & Perspectives, 12(5). https://doi.org/10.1002/prp2.70009

Vancouver

Kurtov M, Rubinić I, Likić R. The endocannabinoid system in appetite regulation and treatment of obesity. Pharmacology Research & Perspectives. 2024;12(5). doi:10.1002/prp2.70009

BibTeX
@article{Kurtov2024,
  author = {Kurtov, Marija and Rubinić, Igor and Likić, Robert},
  title = {The endocannabinoid system in appetite regulation and treatment of obesity},
  journal = {Pharmacology Research & Perspectives},
  year = {2024},
  volume = {12},
  number = {5},
  doi = {10.1002/prp2.70009}
}
Kostenlos starten →